Kinarus Therapeutics Holding AG announced that its interim-CFO, Mr. Subhasis Roy, who worked as a consultant for the company, is leaving to pursue other opportunities. The CFO role at Kinarus will not be immediately filled. The Company’s financial controller provides continuity; supported by a new external advisor with significant public market experience, the Company has sufficient competencies and capacity to manage its current finances with the diligence required to properly run a listed company in Switzerland.